Urinary Bladder, Overactive
117
9
12
78
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
31 trials with published results (26%)
Research Maturity
78 completed trials (67% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.8%
8 terminated out of 117 trials
90.7%
+4.2% vs benchmark
39%
46 trials in Phase 3/4
40%
31 of 78 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 78 completed trials
Clinical Trials (117)
Does Use of a Pre-Procedure Educational Video for Urodynamic Testing Reduces Anxiety?
Low-Intensity Shock Wave Therapy for Refractory Overactive Bladder in Women
Comparison of the Efficacy of Perineal and Intravaginal Electrical Stimulation in Women With Idiopathic Overactive Bladder
Wearables for the Bladder: an In-home Treatment Feasibility Pilot Study
Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls
NXT Post-Market Clinical Follow-up
Comparison of Concurrent Endoscopic Prostate Surgery With Botox-A Injection and Postoperative Medical Therapy in BPH Patients With Overactive Bladder Symptoms
Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet
Ambulatory Long Length URodynamics Evaluation
INTIBIA Pivotal Study
FemPulse Therapy for Overactive Bladder in Women
A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections
Laser Therapy for Treatment of Urogenital Symptoms in Women
Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder
Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene Therapy
INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive Bladder
The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial
Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity
Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder
Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity